Recently, Brown et al. demonstrated that the blockage of CXCR3 signaling in murine gliomas reduced the recruitment and stemness of tumor-infiltrating lymphocytes (TIL) in vivo [48]. This evidence concerns the gene CXCR3 and central nervous system cancer.